Related Experiment Videos
Neonatal jaundice in 'healthy' very low birthweight infants
1Department of Paediatrics (Neonatal Unit), National University of Singapore.
Insights
Healthy premature infants weighing less than 1500 grams often experience significant neonatal jaundice. Their bilirubin levels peak around day four, indicating a higher incidence and severity compared to mature infants.
Area of Science:
- Neonatology
- Pediatrics
- Perinatal Medicine
Background:
- Neonatal jaundice is common in premature infants.
- Very low birthweight (VLBW) infants are particularly susceptible.
- Understanding bilirubin trends in 'healthy' VLBW infants is crucial.
Purpose of the Study:
- To determine daily bilirubin levels in the first week of life for VLBW infants.
- To assess the incidence and severity of hyperbilirubinemia in this population.
- To compare jaundice severity in VLBW infants versus mature infants.
Main Methods:
- Prospective study of 94 premature VLBW infants (<1500g).
- Daily monitoring of serum bilirubin levels during the first week of life.
- Identification of infants requiring phototherapy for hyperbilirubinemia (bilirubin > 260 mumol/l).
Main Results:
- Mean peak bilirubin levels occurred on day 4 (188.1 mumol/l).
- 28% of infants developed hyperbilirubinemia requiring phototherapy.
- 81% of infants had bilirubin levels > 170 mumol/l, significantly higher than mature infants.
Conclusions:
- 'Healthy' VLBW infants exhibit a higher incidence and severity of neonatal jaundice.
- Bilirubin levels in VLBW infants frequently exceed thresholds seen in mature infants.
- The method of delivery did not impact bilirubin levels in this cohort.
Abstract:
The daily bilirubin levels during the first week of life in 94 premature very low birthweight (VLBW, less than 1500 g) relatively 'healthy' infants were determined. Mean daily bilirubin values peaked on the fourth day of life at 188.1 mumol/l (s.e.m. = 5.3). Twenty-eight infants developed hyperbilirubinaemia (bilirubin greater than 260 mumol/l), at which time they were exposed to phototherapy. When individual peak bilirubin values were evaluated, the overall peak value was 213.9 mumol/l (s.e.m. = 5.1) occurring at 4.81 days (s.e.m. = 0.11), although the value is most likely an underestimate, since the 28 pre-phototherapy values were not truly peak values. Seventy-six (81%) infants experienced bilirubin levels greater than 170 mumol/l. The method of delivery apparently had no impact on the bilirubin levels. All the infants remained well and progressed satisfactorily. 'Healthy' VLBW infants experience a much greater incidence and severity of neonatal jaundice than mature infants with the same clinical status.